My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Bio-Techne Corp - Common Stock (NQ:TECH)

57.39 -0.76 (-1.31%)

Streaming Delayed Price Updated: 12:35 PM EST, Nov 19, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Bio-Techne Corp - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stocks That Hit 52-Week Lows On Monday ↗

October 02, 2023

On Monday, 369 companies set new 52-week lows.

Via Benzinga

3 Healthcare Stocks That Should Be on Every Investor’s Radar This Fall ↗

September 23, 2023

The beauty of healthcare stocks is that they tend to do well in most economic conditions because you can’t live without them.

Via InvestorPlace

Bio-Techne's Ex-Dividend Date Is Thursday, Here's What You Need To Know ↗

August 14, 2023

Via Benzinga

Nurturing Growth: Bio-Techne Supports Investors with Growing Earnings ↗

August 08, 2023

Via Benzinga

This Favorable Sign Appears On Bio-Techne's Chart ↗

May 31, 2023

Via Benzinga

Life Science Firm Bio-Techne's Success Formula: Astute Acquisitions Offering Transformation ↗

August 28, 2023

William Blair has initiated coverage on coverage of Bio-Techne Corp (NASDAQ: TECH) with a

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 28, 2023 ↗

August 28, 2023

Via Benzinga

3 Biotech Stocks to Buy Before the Breakout ↗

July 28, 2023

Explosive growth and rapid innovation lie ahead for these three biotechnology stocks, making them the ones to watch.

Via InvestorPlace

Bio-Techne's Acquisition of Lunaphore Expands Its Spatial Biology Offerings ↗

June 22, 2023

Bio-Techne Corporation (NASDAQ: TECH) has agreed to acquire Lunaphore Inc with

Via Benzinga

What 4 Analyst Ratings Have To Say About Bio-Techne ↗

May 04, 2023

Via Benzinga

Bio-Techne: Q3 Earnings Insights ↗

May 03, 2023

Via Benzinga

Thursday Is Your Last Chance To Buy Bio-Techne Before The Dividend Payout ↗

February 07, 2023

Via Benzinga

Lunaphore to Get Acquired by Bio-Techne

June 22, 2023

From Lunaphore

Via Business Wire

Abcam Downgrade: Analyst Trims Expectations Amid Activist Investor Engagement and Potential Bid Anticipation ↗

June 20, 2023

RBC Capital Markets has downgraded Abcam PLC (NASDAQ: ABCM) from Outperform to Sector Perform with a price target of $22,

Via Benzinga

This Analyst With 83% Accuracy Rate Sees Around 11% Upside In Texas Roadhouse - Here Are 5 Stock Picks For Last Week From Wall Street's Most Accurate Analysts ↗

May 08, 2023

U.S stocks closed higher on Friday, with the Dow Jones jumping more than 500 points during the session.

Via Benzinga

Analyst Expectations for Bio-Techne's Future ↗

February 03, 2023

Via Benzinga

Earnings Outlook For Bio-Techne ↗

February 01, 2023

Via Benzinga

Bio-Techne: Q1 Earnings Insights ↗

November 01, 2022

Bio-Techne (NASDAQ:TECH) reported its Q1 earnings results on Tuesday, November 1, 2022 at 06:30 AM. Here's what investors need to know about the announcement.

Via Benzinga

7 Biotech Stocks That Could Cure Your Portfolio Woes ↗

April 19, 2023

If you want to revitalize your portfolio with some exciting opportunities, these biotech stocks to buy might fit the bill.

Via InvestorPlace

5 Cheapest Health Care Stocks You Should Think About ↗

January 27, 2023

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Via Benzinga

5 Health Care Stocks That Are Diving - And May Rally ↗

January 19, 2023

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Via Benzinga

5 Most Cheapest Stocks In The Healthcare Sector: Bio-Techne, Mirati Therapeutics And More ↗

December 15, 2022

The most oversold stocks in the healthcare sector presents an opportunity to buy into undervalued companies.

Via Benzinga

Our 7 Top Biotech Stock Picks for 2023 ↗

December 09, 2022

Following the devastation of Covid-19, there’s greater interest toward medical innovations, thus bolstering biotech stock picks for 2023.

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For January 10, 2023 ↗

January 10, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022 ↗

December 14, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For December 12, 2022 ↗

December 12, 2022

Via Benzinga

Earnings Scheduled For November 1, 2022 ↗

November 01, 2022

Companies Reporting Before The Bell • BP (NYSE:BP) is estimated to report quarterly earnings at $2.07 per share on revenue of $64.76 billion.

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

September 19, 2022

On Monday, 429 stocks made new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

September 16, 2022

During Friday's session, 574 stocks hit new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

September 14, 2022

During Wednesday's session, 265 companies made new 52-week lows.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.